Opioid Induced Constipation Drugs Market was valued at USD 2.5 Billion in 2022 and is projected to reach USD 4.3 Billion by 2030, growing at a CAGR of 7.5% from 2024 to 2030.
The global opioid-induced constipation (OIC) drugs market was valued at approximately USD 5.6 billion in 2022 and is anticipated to experience a compound annual growth rate (CAGR) of 7.4% from 2023 to 2030. The increasing prevalence of opioid use for managing chronic pain, coupled with the rising awareness about OIC, is driving this growth. Additionally, the introduction of novel therapeutics and the growing investment in research and development are contributing to the market's expansion. The segment's growth is further supported by an aging population and the rising incidence of conditions requiring long-term opioid therapy.
Opportunities within the market are significant, particularly in emerging regions such as Asia-Pacific and Latin America, where healthcare infrastructure improvements and increasing healthcare access are enhancing the market landscape. The growing focus on personalized medicine and the development of targeted OIC treatments present substantial opportunities for market players. Furthermore, the advancement in drug delivery systems and the expansion of clinical trials for novel OIC therapies are expected to open new avenues for market growth and innovation in the coming years.
Get an In-Depth Research Analysis of the Global Opioid Induced Constipation Drugs Market Size And Forecast [2025-2032]
Ironwood Pharmaceuticals Inc Daiichi Sankyo Co Ltd
Pfizer
Progenics Pharmaceuticals Inc Shionogi & Co.
Ltd
Allergan Plc
Nektar Therapeutics
Purdue Pharma
S.L.A. Pharma AG
Mundipharma International Limited
Ono Pharmaceutical Co.
Ltd
Takeda Pharmaceutical Company Limited
Theravance Biopharma Inc Valeant Pharmaceuticals International
Cosmo Pharmaceuticals SA
Daewoong Pharmaceutical
C.B. Fleet Company
Sucampo Pharmaceuticals
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Opioid Induced Constipation Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Opioid Induced Constipation Drugs Market
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on Types the Market is categorized into Below types that held the largest Opioid Induced Constipation Drugs market share In 2023.
Lubiprostone
Methyl Naltrexone Bromide
Naldemedine
Alvimopan
Other
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Opioid Induced Constipation Drugs Market Research Analysis
1. Introduction of the Global Opioid Induced Constipation Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Opioid Induced Constipation Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Opioid Induced Constipation Drugs Market, By Type
6. Global Opioid Induced Constipation Drugs Market, By Application
7. Global Opioid Induced Constipation Drugs Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Opioid Induced Constipation Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/